Journal of the American Academy of Dermatology 2002: Vol 47 Index

29 Pages·2002·10.1 MB·English

index to volume 47 Aste N, Fumo G, Contu F, Aste N, Biggio P. Nail pigmentation
caused by hydroxyurea: report of 9 cases. 2002;:47:146-7 (Brief
rep.)
Aste N (see Aste et al). 2002;47:146-7 (Brief rep.)
Author index*
Au S, Crawford RI. Three-dimersional analysis of a calciphylaxis
plaque: clues to pathogenesis. 2002;47:53-7
A
Audhuy B (see Grange et al). 2002;47:530-4
Abdulghani AA (see Gottlieb et al). 2002;47:692-700
Axelrod FB (see Zaenglein et al). 2002;47:445-7 (Case rep.)
Acevedo A (see Ruiz-Rodriguez et al). 2002;47:740-2 (Therapy)
Azizlerli G (see Baykal et al). 2002;47:875-80
Adams BB, Gloster HM. Surgical pearl: excision with suprakeloi-
dal flap and radiation therapy for keloids. 2002;47:307-9
B
(Pearls)
Bagheri S, Nichols K, PUVA Follow Up Study (see Stern et al)
Adams BB. Tinea corporis gladiatorum. 2002;47:286-90 (Clin.
2002;47:33-9
rev.)
Baran R, Perrin C. Bowen’s disease clinically simulating an ony-
Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation
chomatricoma. 2002;47:947-9 (Case rep.)
of lentigo maligna with permanent sections: implications re-
Baran R. Pyogenic granuloma-like lesions associated with topical
garding current guidelines. 2002;47:743-8 (Derm. surgery)
retinoid therapy. 2002;47:970 (Letters: notes & comments)
Ahmed AR (see Engineer et al). 2002;47:943-6 (Case rep.)
Baran R (see Skowron et al). 2002;47:S187-8 (Case rep.)
Ahmed DDF (see Elston et al). 2002;47:291-9 (Periodic synopsis)
Barbagallo JS (see Freudenthal and Barbagallo). 2002;47:722-6
* Ahmed I, Tope WD, Young TL, Miller DM, Bloom KE. Neurocu-
Barbosa IL (see Correia et al). 2002;47:58-62
taneous melanosis in association with encephalocraniocutane-
Barnes CJ (see Sangueza et al). 2002;47:251-7
ous lipomatosis. 2002;47:5196-200 (Case rep.)
Barnetson RS (see Satchell et al). 2002;47:852-5
Akagi A, Tajima S, Kawada A, Ishibashi A. Coexistence of pseu-
Barnette DJ (see Ross et al). 2002;47:263-70 (Therapy)
doxanthoma elasticum-like papillary dermal elastolysis and lin-
Bart RS (see Gelbard et al). 2002;47:224-30
ear focal dermal elastosis. 2002;47:S189-92 (Case rep.)
Bauer JW (see Szeimies et al). 2002;47:258-62 (Therapy)
Al Aboud K (see Alfadley et al). 2002;47:S275-8 (Case rep.)
Baumann L (see Shah et al). 2002;47:241-4
Al Hawsawi K (see Alfadley et al). 2002;47:5275-8 (Case rep.)
Baykal C, Azizlerli G, Thoma-Uszynski S$, Hert M. Pemphigus
Alam M, Bickers DR. Airbag trauma induced cutaneous fistulae in
vulgaris localized to the nose and cheeks. 2002;47:875-80
a heart transplant patient. 2002;47:S175-6 (Case rep.)
Alavi A (see Shapiro et al). 2002;47:623-8 (Brief rep.) Beitz J (see Brinker et al). 2002;47:798-9 (Letter: notes & com-
ments)
Albert MR, Ostheimer KG. The evolution of current medical and
popular attitudes toward ultraviolet light exposure: part 1 Bell C (see Satchell et al). 2002;47:852-5
2002;47:930-7 (History) Bell K (see Chen et al). 2002;47:940-1 (Pearls)
Alefacept Clinical Study Group (see Krueger et al). 2002;47:821-33 Belsito DV (see Shackelford and Belsito). 2002;47:715-21
Alfadley A, Al Hawsawi K, Hainau B, Al Aboud K. Two brothers Benedetto AV, Benedetto EA, Griffin TD. Basal cell carcinoma
with keratosis follicularis spinulosa decalvans. 2002;47:S275-8 presenting as a large pore. 2002;47:727-32
(Case rep.) Benedetto EA (see Benedetto et al). 2002:47:727-32
| Aliaga A (see Pérez et al). 2002;47:21- Berg D, Otley CC. Skin cancer in organ transplant recipients:
Allen RS (see Gottlieb et al). 2002;47:692-700 epidemiology, pathogenesis, and management. 2002;47:1-17
| Alli N, Toy GG. Familial Mediterranean fever: attacks during (CME article)
| isotretinoin treatment. 2002;47:967 (Letters: case notes) Bergfeld WF (see Tosti et al). 2002;47:636-7 (Letter)
j Allison DS, el-Azhary RA, Calobrisi SD, Dicken CH. Pityriasis Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review
rubra pilaris in children. 2002;47:386-9 and update on the molecular basis of pathophysiology. 2002;
Almeida ART (see Kadunc et al). 2002;47:129-31 (Pearls) 47:109-87 (CME article)
AlvarezJG (see Ruiz-Rodriguez et al). 2002;47:740-2 (Therapy) Berman B, Kaufman J. Pilot study of the effect of postoperative
Alvarez-Cuesta C, Raya-Aguado C, Vasquez-L6pez F, Garcia PB, imiquimod 5% cream on recurrence rate of excised keloids
Pérez-Oliva N. Nevus of Ota associated with ipsilateral deaf- 2002;47:5209-11 (Case rep.)
ness. 2002;47:5257-9 (Case rep.) Bernardo L (see Pujol et al). 2002;47:S168-71 (Case rep.)
Al-Waiz M (see Sharqu|i e et al). 2002;47:159-60 (Letter repPltyy ) Bernert RA (see Smith et al). 2002;47:749-54 (Dermatopathology)
Anderson RR (see Yun et al). 2002;47:542-7 Beutner EH, Pelton S, Hashimoto T, Xu Y, Plunkett RW, Korman
Andres K (see Geisse et al). 2002;47:390-8 NJ, Helm TN, Jablonska S. A nonfatal case and 2 fatal cases of
AndrewsJ S (see Lehmann et al). 2002;47:231-40 paraneoplastic pemphigus: can a complement indirect immu-
Antonovich D, Whalen JD. Surgical pearl: marking of cutaneous nofluorescent test help to identify fatal “group A” paraneoplas-
excisional specimens for orientation. 2002;4 6 (Pearls) tic pemphigus cases?. 2002;47:841-51
Anveden I (see Swartling et al). 2002;47:067-71 Bickers DR (see Alam and Bickers). 2002;47:5175-6 (Case rep.)
| Apisarnthanarax N (see Talpur et al). 2002;47:672-84 Biggio P (see Aste et al). 2002;47:146-7 (Brief rep.)
Aractingi S (see Eliaszewicz et al). 2002;47:40-6 Blanco A (see Pujol et al). 2002;47:S168-71 (Case rep.)
Argenziano G (see Pizzichetta et al). 2002;47:137-9 (Case rep.) Blauvelt A (see Rubenstein et al). 2002;47:300-3 (Special report)
Aronson I (see Geraminejad et al). 2002;47:641-55 (CME article) Blauvelt A (see Weiss et al). 2002;47:512-7
Asan Y (see Kubo et al). 2002;47:148-51 (Brief rep.) Bleeker MCG, Hogewoning CJA, van den Brule AJC, Voorhorst FJ,
van Andel RE, Risse EKJ, Starink TM, Meijer CJLM. Penile
lesions and human papillomavirus in male sexual partners of
*July, pp. 1-168; August, pp. 169-326, $165-204; September, pp. women with cervical intraepithelial neoplasia. 2002:47:351-7
327-406; October, pp. 467-640, $205-48; November, pp. 641- Blewitt RW (see Kirby et al). 2002;47:5165-7 (Case rep.)
808, S249-88; December, 809-1006 Bloom KE (see Ahmed et al). 2002;47:5196-200 (Case rep.)
J Am AcaD DERMATOI DECEMBER 2002 979
980 Author index ] AM ACAD DERMATOL
DECEMBER 2002
Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, Hachem ‘alzavara-Pinton P, Capezzera R, Zane C, De Panfilis G. Medium-
R, Raad I. Skin lesions associated with Fusarium infection. dose ultraviolet Al therapy for pityriasis lichenoides et variol-
2002:47:659-66 iformis acuta and pityriasis lichenoides chronica. 2002;47:410-4
Bogle MA, Hwang LY, Tschen JA. Acrokeratoelastoidosis. 2002; (Therapy)
+7:448-51 (Case rep.) ‘alzavara-Pinton PG (see Szeimies et al). 2002;47:258-62 (Thera-
Boktour M (see Bodey et al). 2002;47:659-66 Py )
Bolognia JL (see Willey et al). 2002;47:453 (Letter) camacho F (see Tosti et al). 2002;47:636-7 (Letter)
Bordalo O (see Matura et al). 2002;47:709-14 Camara C (see Pipitone et al). 2002;47:118-23 (Current issues)
Bordes R (see Pujol et al). 2002;47:5168-71 (Case rep.) ‘ampilho F (see Correia et al). 2002;47:58-62
Boucher KW, Davidson K, Mirakhur B, Goldberg J, Heymann WR. ‘apezzera R (see Calzavara-Pinton et al). 2002;47:410-4 (Therapy)
Paronychia induced by cetuximab, an antiepidermal growth carey W (see Pereira et al). 2002;47:5172-4 (Case rep.)
factor receptor antibody. 2002;47:632-3 (Letter) ‘arrasco D, vander Straten M, Tyring SK. Treatment of anogenital
Boulinguez S, Viraben R. Cutaneous Bacillus cereus infection in warts with imiquimod 5% cream followed by surgical excision
an immunocompetent patient. 2002;47:324-5 (Letter) of residual lesions. 2002;47:S212-6 (Case rep.)
Bourgault-Villada I (see Eliaszewicz et al). 2002;47:40-6 -arucci JA, McGovern TW, Norton SA, Daniel CR, Elewski BE,
Bouwhuis SA, el-Azhary RA, Gibson LE, McEvoy MT, Pittelkow Fallon-Friedlander S$, Lushniak BD, Taylor JS, Warschaw K,
MR. Effect of insulin-dependent diabetes mellitus on response Wheeland RG. Cutaneous anthrax management algorithm.
to extracorporeal photopheresis in patients with Sézary syn- 2002;47:700-9 (From the Academy)
drome. 2002;47:063-7 -audell MD (see Sangueza et al). 2002;47:251-7
Bowen GM (see Agarwal-Anta! et al). 2002;47:743-8 (Derm. sur- saumes E (see Eliaszewicz et al). 2002;47:40-6
gery) selebi JT (see Ward et al). 2002;47:493-6
Bowman PH (see Zackheim et al). 2002;47:155-7 (Letter) ‘erroni L (see Grange et al). 2002;47:530-4
Boyd AS. Use of mycophenolate mofetil in erythema nodosum. verroni L (see Kaddu et al). 2002;47:423-8 (Dermatopathology)
2002;47:908-9 (Letters: case notes) ervera C (see Persaud et al). 2002;47:553-6
Boyd AS, King LE Jr. Thalidomide-induced remission of lichen shalline D (see Eliaszewicz et al). 2002;47:40-6
planopilaris. 2002;47:967-8 (Letters: case notes) thamlin SL, Kao J, Frieden IJ, Sheu MY, Fowler AJ, Fluhr JW,
Boyer JD, Maino KL, ZitelliJ A. Surgical pearl: hemostasis assisted Williams ML, Elias PM. Ceramide-dominant barrier repair lipids
with two skin hooks. 2002;47:938-9 (Pearls) alleviate childhood atopic dermatitis: changes in barrier func-
Boyer JD, Zitelli JA, Brodland DG, D'Angelo G. Local control of tion provide a sensitive indicator of disease activity. 2002;47:
primary Merkel cell carcinoma: review of 45 cases treated with 198-208
Mohs micrographic surgery with and without adjuvant radia- champagne P (see Sauder et al). 2002;47:535-41
tion. 2002;47:885-92 (Derm. surgery) than HH. Photorejuvenation or photoaging: where does one
Braathen L (see Szeimies et al). 2002;47:258-62 (Therapy) draw the fine line?. 2002:47:321-2 (Letter)
Braverman IM (see Engineer et al). 2002;47:943-6 (Case rep.) shan LS (see Berlin et al). 2002;47:169-87 (CME article)
Breuer-McHam J (see Talpur et = al). 2002;47:672-84, chang MW (see Zaenglein et al). 2002;47:445-7 (Case rep.)
2002;47:085-91 charles AJ Jr, Otley CC, Pond GR. Prognostic factors for life
Brinker A, Trontell A, Beitz J. Pregnancy and pregnancy rates in expectancy in nonagenarians with nonmelanoma skin cancer:
association with isotretinoin (Accutane). 2002;47:798-9 (Letter implications for selecting surgical candidates. 2002;47:419-22
notes & comments) (Derm. surgery)
Brinster NK (see Goyal et al). 2002;47:5201-4 (Case rep.). Correc thartier MB, Hoss DM, Grant-Kels JM. Approach to the aduit
tion 2002;47:972 female patient’ with diffuse = nonscarring alopecia
Brécker E-B (see Schmidt et al). 2002;47:133-6 (Case rep.) 2002;47:809-18 (CME article)
Brécker E-B (see Shimanovich et al). 2002;47:780-4 (Case rep.) haudhari U (see Gottlieb et al). 2002;47:692-700
Brodland DG (see Boyer et al). 2002;47:885-92 (Derm. surgery) then SC (see McCall and Chen). 2002;47:524-9
Brown HA, Gibson LE, Pujol RM, Lust JA, Pittelkow MR. Primary then SC (see Rubenstein et al). 2002;47:300-3 (Special report)
follicular mucinosis: long-term follow-up of patients younger then TM, Bell K, Orengo I. Surgical pearl: behold the lowly cup.
than 40 years with and without clonal T-cell receptor gene 2002;4 7:940-1 (Pearls)
rearrangement. 2002;47:856-62 vhittineni B (see Pipitone et al). 2002;47:118-23 (Current issues)
Brown SK, Heilman ER. Granular parakeratosis: resolution with hiu A, Kohler $, McGuire J, Kimball AB. Cytarabine-induced
topical tretinoin. 2002;47:S79-280 (Case rep.) acute generalized exanthematous pustulosis. 2002;47:633-5
Brown TJ, McCrary M, Tyring SK. Antiviral agents: nonantiviral (Letter)
drugs. 2002;47:581-99 (Clin. rev.). Correction 2002;47:972 shosidow O (see Eliaszewicz et al). 2002;47:40-6
Bugdodel R (see Shah et al). 2002;47:241-4 thosidow O (see Poszepezynska-Guigné et al). 2002;47:47-52
Burkhart CG, Gupta AK (see Burkhart et al). 2002;47:629-31 Christiano AM (see Henn et al). 2002;47:519-23
(Commentary) Chung KY (see Lee and Chung). 2002;47:578-80 (Derm. surgery)
Burkhart CN, Burkhart CG, Gupta AK. Dermatophytoma: recalci- Ciambellotti A (see Gallo et al). 2002;47:633 (Letter)
trance to treatment because of existence of fungal biofilm Clark AH (see Mahendran et al). 2002;47:620-2 (Brief rep.)
2002;47:629-31 (Commentary) Cockerell CJ (see Curry et al). 2002;47:926-9 (Special report)
Burnier MN Jr. (see Pereira et al). 2002;47:5172-4 (Case rep.) Cohen AD (see Halevy et al). 2002;47:311-3 (Brief rep.)
Bystryn J-C, Jiao D, Natow S. Treatment of pemphigus with Cohen B (see DeAmicis et al). 2002;47:5273-4 (Case rep.)
intravenous immunoglobulin. 2002;47:358-63 Cohen JL, Keoleian CM, Krull EA. Penile paraffinoma: self-injec-
tion with mineral oil. 2002;47:5251-3 (Case rep.)
¢ Coleman WP III (see Lawrence and Coleman). 2002;47:105-8
Callis KP (see Krueger and Callis). 2002;47:972 (Letters: notes & (Periodic synopsis)
comments) (Reply) Collison DW (see Omura et al). 2002;47:950-3 (Case rep.)
Calobrisi SD (see Allison et al). 2002:47:386-9 Colombo MD (see Tosti et al). 2002;47:73-6 (Therapy)
J} AM ACAD DERMATOL Author index 981
VOLUME 47, NUMBER 6
Combemale P (see Skowron et al). 2002;47:5187-8 (Case rep.) Dong H (see Kaddu et al). 2002;47:423-8 (Dermatopathology)
Conner K, Nern K, Rudisell J, O'Grady T, Gallo RL. The antimi- Dotson D (see Maloney et al). 2002;47:614-6 (Case rep.)
crobial peptide LL-37 is expressed by keratinocytes in condy- Dow EC (see Engineer et al). 2002;47:943-6 (Case rep.)
loma acuminatum and verruca vulgaris. 2002;47:347-50 Drage LA, Davis MDP, de Castro F, Van Keulen V, Weiss EA,
Contu F (see Aste et al). 2002;47:(1Br4ie0f -re7p .) Gleich GJ, Leiferman KM. Evidence for pathogenic involve-
Cooke LM (see Ross et al). 2002;47:263-70 (Therapy) ment of eosinophils and neutrophils in Churg-Strauss syn-
Cordoba S (see Ruiz-Rodriguez et al). 2002;47:740-2 (Therapy) drome. 2002;47:209-16
Correia O, Delgado L, Barbosa IL, Campilho F, Fleming-Torrinha Dubertret L (see Poszepezynska-Guigné et al). 2002;47:47-52
J. Increased interleukin 10, tumor necrosis factor @ and inter- Duncan R (see Shah et al). 2002;47:241-4
leukin 6 levels in blister fluid of toxic epidermal necrolysis. Dunlap FE (see Olsen et al). 2002;47:377-85
2002;47:58-62 Duong DJ, Moxley RT Ill, Kellman RM, Pincus SH, Gaspari AA
Cowen E, Mercurio MG, Gaspari AA. An open case series of Thalidomide therapy for cicatricial pemphigoid. 2002;47:S193-5
patients with basal cell carcinoma treated with topical 5% (Case rep.)
imiquimod cream. 2002;47:5240-8 (Case rep.) Dupin M (see Skowron et al). 2002;47:S187-8 (Case rep.)
Cozzani E (see Gallo et al). 2002;47:633 (Letter) Dupont E (see Sauder et al). 2002;47:535-41
Crawford RI (see Au and Crawford). 2002;47:53-7 Dupree NE (see Taylor et al). 2002;47:770-3 (Special report)
Croteau D (see Sauder et al). 2002;47:535-41 Duvic M (see Bodey et al). 2002;47:659-66
Cullen DR (see Shum et al). 2002;4 33-9 Duvic M (see Koay et al). 2002;47:608-10 (Case rep.)
Cunningham NM (see Rabeni and Cunningham). 2002;47:797-8 Duvic M (see Maloney et al). 2002;47:969-70 (Letters: notes &
(Letter: case notes) comments)
Curry JA (see Curry et al). 2002;47:926-9 (Special report) Duvic M (see Talpur et al). 2002;47:672-84, 2002:47:685-91
Curry ML, Curry JA, Cockerell CJ. Dermatology and the Americans Dytoc MT (see Grimes et al). 2002;47:789-91 (Brief rep.)
With Disabilities Act: a review of the case law. 2002;47:926-9
(Special report) E
Eaglstein WH (see Kirsner et al). 2002;47:158 (Letter reply)
D Eichenfield L (see Fleischer et al). 2002;47:562-70 (Therapy)
Da Raeve L, Roseeuw D, OttenJ . Multiple cutaneous granular cell el-Azhary RA, Yiannias JA. Allergic contact dermatitis to epoxy
tumors in a child in remission for Hodgkin's disease. 2002;47: resin in immersion oil for light microscopy. 2002;47:954-5 (Case
$180-2 (Case rep.) rep.)
Dahl MV. Imiquimod: a cytokine inducer. 2002;47:5205-8 (Case el-Azhary RA (see Allison et al). 2002;47:386-9
rep.) el-Azhary RA (see Bouwhuis et al). 2002;47:63-7
Dahl PR, Perniciaro C, Holmkvist KA, O’Connor MI, Gibson LE Elewski BE. Infliximab for the treatment of severe pustular pso-
Fulminant group A streptococcal necrotizing fasciitis: clinical riasis. 2002;47:796-7 (Letter: case notes)
and pathologic findings in 7 patients. 2002;47:489-92 Elewski BE (see Carucci et al). 2002;47:766-9 (From the Academy)
D'Angelo G (see Boyer et al). 2002;47:885-92 (Derm. surgery) Elias PM (see Chamlin et al). 2002;47:198-208
Daniel CR (see Carucci et al). 2002;47:766-9 (From the Academy) Eliaszewicz M, Flahault A, Roujeau J-C, Fillet AM, Challine D,
Darling TN (see Rubenstein et al). 2002;47:300-3 (Special report) Mansouri S$, Wolkenstein P, Aractingi S, Penso-Assathiany D,
Davidson K (see Boucher et al). 2002;47:632-3 (Letter) Maslo C, Bourgault-Villada I, Chosidow O, Caumes E. Prospec-
Davis LS (see Sangueza et al). 2002;47:251-7 tive evaluation of risk factors of cutaneous drug reactions to
Davis MDP (see Drage et al). 2002;47:209-16 sulfonamides in patients with AIDS. 2002;47:40-6
Dawber RPR (see Tosti et al). 2002:47:636-7 (Letter) Ellis CN (see Krueger et al). 2002;47:821-33
de Castro F (see Drage et al). 2002;47:209-16 Elpern DJ. The care of patients. 2002;47:317-8 (Beneath the sur-
de Giacomi C (see Pizzichetta et al). 2002;47:137-9 (Case rep.) face)
De Jong MCJM (see Vodegal et al). 2002;47:919-25 (Review) Flston DM, Ahmed DDF, Watsky KL, Schwarzenberger K. Hand
De Panfilis G (see Calzavara-Pinton et al). 2002;47:410-4 (Thera- dermatitis. 2002;47:291-9 (Periodic synopsis)
py) Elston DM. Medical pearl: fluorescence microscopy of hematoxy-
DeAmicis T, Mofid MZ, Cohen B, Nousari HC. Hypocomple- lin-eosin—stained sections. 2002;4 -9 (Pearls)
mentemic urticarial vasculitis: report of a 12-year-old girl with Elston DM (see Ritter et al). 2002;4 :323-4 (Letter)
systemic lupus erythematosus. 2002;47:5273-4 (Case rep.) Elston DM (see Smith et al). 2002;4 49-54 (Dermatopathology)
DeKoven J (see Saucer et al). 2002;47:535-41 Emanuel EJ (see Weiss et al). 2002;47.512-7
Delgado L (see Correia et al). 2002;47:58-62 Emmerich J (see Poszepezynska-Guigné et al). 2002;47:47-52
Dermatologic Consortium for Women’s Health (see Olsen et al) Emtestam L (see Lapins et al). 2002;47:280-5 (Laser surgery)
2002;47:795 (Commentary) Engineer L, Dow EC, Braverman IM, Ahmed AR. Epidermolysis
di Chiacchio N (see Kadunce et al). 2002;47:129-31 (Pearls) bullosa acquisita and multiple myeloma. 2002;47:943-6 (Case
Dichmann S$, Mrowietz U, Schépf E, Norgauer J. Humanized rep.)
monoclonal anti-CD25 antibody as a novel therapeutic option Erés N, Karolyi Z, Kovacs A, Takacs I, Radvanyi G, Kelényi G.
in HIV-associated psoriatic erythroderma. 2002;47:635-6 (Let- Intravascular B-cell lymphoma. 2002;47:5260-2 (Case rep.)
ter) European Organization for Research and Treatment of Cancer
Dicken CH (see Allison et al). 2002;47:386-9 (EORTC) Cutaneous Lymphoma Project Group (see Jones et al)
Dittberner T, Schéttler E, Ranze O, Greinacher A, Knobler R 2002;47:304-70
Heparin-induced thrombocytopenia: a complication in extra-
F
corporeal photochemotherapy (photopheresis). 2002;4 452-3
(Letter) Faisant M (see Skowron et al). 2002;47:5187-8 (Case rep.)
Dittmar HC (see Szeimies et al). 2002;47:258-62 (Therapy) Falabella AF (see Kirsner et al). 2002;47:158 (Letter reply)
Doi R (see Uetsu et al). 2002;47:881-4 (Therapy) Fallon-Friedlander S (see Carucci et al). 2002;47:766-9 (From the
Doney KC (see Masood et al). 2002;47:140-5 (Brief rep.) Academy)
982 Author index J} AM ACAD DERMATOL
DECEMBER 2002
Fantini F, Kovacs E, Scarabello A. Unilateral transient acantholytic SK. Kaposi’s sarcoma and other manifestations of human her-
dermatosis (Grover’s disease) along Blaschko lines. 2002;47: pesvirus 8. 2002;47:641-55 (CME article)
319-20 (Letter) Gerbig AW. Treating keratosis pilaris. 2002;47:457 (Letter)
Fefer A (see Masood et al). 2002;47:140-5 (Brief rep.) Gerwels JW (see Agarwal-Antal et al). 2002;47:743-8 (Derm. sur-
Feldman SR (see Sugarman et al). 2002;47:217-2? gery)
Fillet AM (see Eliaszewicz et al). 2002;47:40-6 Ghetti E (see Tosti et al). 2002;47:73-6 (Therapy)
Fisher SG (see Pipitone et al), 2002;47:118-23 (Current issues) Gibson LE (see Bouwhuis et al). 2002;47:63-7
Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP. Gibson LE (see Brown et al). 2002;47:856-62
Aggressive management of juvenile dermatomyositis results in Gibson LE (see Dahl et al). 2002;47:489-92
improved outcome and decreased incidence of calcinosis. Ginkel A (see Geisse et al). 2002;47:390-8
2002:47:505-11 Glaser DA (see Spray and Glaser). 2002;47:S177-9 (Case rep.)
Fivenson DP (see Gathers et al). 2002;47:191-7 Gleich GJ (see Drage et al). 2002;47:209-16
Flahault A (see Eliaszewicz et al). 2002;47:40-6 Gloster HM. The use of second-intention healing for partial-
Fleischer AB Jr., Ling M, Eichenfield L, Satoi Y, Jaracz E, Rico MJ, thickness Mohs defects involving the vermilion and/or mucosal
Maher RM. Tacrolimus ointment for the treatment of atopic surfaces of the lip. 2002;47:893-7 (Derm. surgery)
dermatitis is not associated with an increase in Cutaneous in- Gloster HM (see Adams and Gloster). 2002;47:307-9 (Pearls)
fections. 2002;47:562-70 (Therapy) Glusac EJ (see Willey et al). 2002;47:453 (Letter)
Fleischer AB Jr. (see Sugarman et al). 2002;47:217-23 Gmyrek R (see Ward et al). 2002;47:493-6
Fleischer AB (see Sangueza et al). 2002;47:251-7 Gold R (see Pérez et al). 2002;47:21-7
Fleming-Torrinha J (see Correia et al). 2002;47:58-62 Goldberg J (see Boucher et al). 2002;47:632-3 (Letter)
Flowers FP (see Zampogna et al). 2002;47:5229-35 (Case rep.) Gonzalez S, Tannous Z. Real-time in vivo confocal reflectance
microscopy of basal cell carcinoma. 2002;47:869-74
Flowers MED (see Masood et al). 2002;47:140-5 (Brief rep.)
Goodman SN (see Lehmann et al). 2002;47:231-40
Fluhr JW (see Chamlin et al). 2002;47:198-208
Goossens A (see Matura et al). 2002;47:709-14
Fowler AJ (see Chamlin et al). 2002;47:198-208
Goraya JS, Kaur S. Acute infantile hemorrhagic edema and He-
French LE (see Shapiro et al). 2002;47:950-61 (Case rep.)
noch-Schénlein purpura: is IgA the missing link? 2002;47:801
Freudenthal AR, BarbagalloJS . Ghost anemone dermatitis. 2002;
(Letter: notes & comments)
$7:722-6
Gorman A (see Morrison et al). 2002;47:617-20 (Brief rep.)
Fricke O (see Hinrichs et al). 2002:47:5268-9 (Case rep.)
Gottlieb AB, Lebwohl M, Totoritis MC, Abdulghani AA, Shuey SR,
Fried RG (see Shapiro et al). 2002;47:623-8 (Brief rep.)
Romano P, Chaudhari U, Allen RS, Lizambri RG. Clinical and
Frieden IJ (see Chamlin et al). 2002;47:198-208
histologic response to single-dose treatment of moderate to
Friedli A, Saurat J-H, Harms M. Serpiginous ganglion cyst of the
severe psoriasis with an anti-CD80 monoclonal antibody. 2002;
foot mimicking cutaneous larva migrans. 2002;4 :$200-7 (Case
+7:692-700
rep.)
Goyal S$, Brinster NK, Goyal S. Ki-1(CD30) positive anaplastic
Fuhlbrigge RC (see Fisler et al). 2002;47:505-11
large cell lymphoma: primary nodal disease relapsing as eryth-
Fujii K (see Uetsu et al). 2002;47:881-4 (Therapy)
roderma. 2002;47:S201-4 (Case rep.). Correction 2002;47:972
Fumo G (see Aste et al). 2002;47:146-7 (Brief rep.)
Goyal S (see Goyal et al). 2002;47:S201-4 (Case rep.). Correction
Fung MA. The clinical and histopathologic spectrum of “dermal
2002;47:972
hypersensitivity reactions,” a nonspecific histologic diagnosis
Graham BS (see Ross et al). 2002;47:263-70 (Therapy)
that is not very useful in clinical practice, and the concept of a
Grandi G (see Pizzichetta et al). 2002;47:137-9 (Case rep.)
‘dermal hypersensitivity reaction pattern.” 2002;47:898-907
Grange F, WechslerJ ,G uillaumJe-C , TortelJ ,T ortel M-C, Audhuy
(Dermatopathology )
B, Jaulhac B, Cerroni L. Borrelia burgdorferi-associated lym-
Funicella T (see Olsen et al). 2002;47:377-85
phocytoma cutis simulating a primary cutaneous large B-cell
lymphoma. 2002;47:530-4
G
Grant-KelsJM (see Chartier et al). 2002;47:809-18 (CME article)
Gallardo F (see Pujol et al). 2002;47:5168-71 (Case rep.)
Greer KE (see McClelland et al). 2002;47:962-4 (Case rep.)
Gallo R, Ciambellotti A, Cozzani E, Parodi A. Peristomal allergic Greinacher A (see Dittberner et al). 2002;47:452-3 (Letter)
contact dermatitis caused by Stomahesive paste: an additional Griffin JE (see Sangueza et al). 2002;47:251-7
case. 2002;47:033 (Letter) Griffin TD (see Benedetto et al). 2002;47:727-32
Gallo RL (see Conner et al). 2002:47:347-50 Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repig-
Garcia PB (see Alvarez-Cuesta et al). 2002;47:5257-9 (Case rep.) mentation of vitiligo. 2002;47:789-91 (Brief rep.)
Garcia-Bravo B (see Matura et al). 2002:47:709-14 Gross K (see Geisse et al). 2002:47:390-8
Gaspari AA (see Cowen et al), 2002;47:5240-8 (Case rep.) Grossman ME (see Ward et al). 2002;47:493-6
Gaspari AA (see Duong et al). 2002;47:5193-5 (Case rep.) Grossman N (see Halevy et al). 2002;47:311-3 (Brief rep.)
Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Guill CK (see Orengo et al). 2002;47:5225-8 (Case rep.)
Narrowband UVB phototherapy for early stage mycosis fun- Guillaume J-C (see Grange et al). 2002;47:530-4
goides. 2002;47:191-7 Guin JD. Eyelid dermatitis: experience in 203 cases. 2002;47:
Geisse JK, Rich P, Pandya A, Gross K, Andres K, Ginkel A, Owens 755-65 (Clin. rev.)
M. Imiquimod 5% cream for the treatment of superficial basal Gulliver WP (see Krueger et al). 2002;47:821-33
cell carcinoma: a double-blind, randomized, vehicle-controlled Gupta AK (see Burkhart et al). 2002;47:629-31 (Commentary)
study. 2002:47:390-8
Gelbard SN, Tripp JM, Marghoob AA, Kopf AW, Koenig KL, Kim H
JY, Bart RS. Management of Spitz nevi: a survey of dermatolo- Haas N, Henz BM, Weigel H. Congenital miliaria crystallina.
gists in the United States. 2002;:47:224-30 2002;47:5270-2 (Case rep.)
George R (see Ritter et al). 2002;47:3223 -4 (Letter) Hachem R (see Bodey et al). 2002;47:659-66
Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring Hainau B (see Alfadley et al). 2002;47:5275-8 (Case rep.)
}) AM ACAD DERMATOL Author index 983
VOLUME 47, NUMBER 6
Halevy S, Cohen AD, Lunenfeld E, Grossman N. Autoimmune Ikejima A (see Suga et al). 2002;47:435-8 (Pearls)
progesterone dermatitis manifested as erythema annulare cen- loffreda MD (see Youker et al). 2002;47:322-3 (Letter)
trifugum: confirmation of progesterone sensitivity by in vitro Ishibashi A (see Akagi et al). 2002;47:S189-92 (Case rep.)
interferon-y release. 2002;47:311-3 (Brief rep.) Ishii M (see Kato et al). 2002;47:5287-8 (Case rep.)
Handl-Zeller L (see Jones et al). 2002;47:364-70 Izquierdo MJ (see Pérez et al). 2002;47:21-7
Happle R (see Tosti et al). 2002;47:636-7 (Letter)
Harms M (see Friedli et al). 2002;47:5206-7 (Case rep.) ]
Harris A (see Millard et al). 2002;47:801-2 (Letter reply: notes & Jablonska S (see Beutner et al). 2002;47:841-51
comments) Jaén P (see Ruiz-Rodriguez et al). 2002;4 7:740-2 (Therapy)
Hashimoto T (see Beutner et al). 2002;47:841-51 Jaracz E (see Fleischer et al). 2002;4 562-70 (Therapy)
Hashimoto T (see Nitta et al). 2002;47:S283-6 (Case rep.) Jaulhac B (see Grange et al). 2002;4 :530-4
Hashimoto T (see Shimanovich et al). 2002;47:780-4 (Case rep.) Jaworsky C (see Jih et al). 2002;47:908-13 (Clin. rev.)
Hassenein AM (see Zampogna et al). 2002;47:5229-35 (Case rep.) Jiao D (see Bystryn et al). 2002;47:358-63
He J (see Shah et al). 2002;47:241-4 Jih DM, Salcedo SL, Jaworsky C. Benign cephalic histiocytosis: a
Hegarty AM, Hodgson TA, Lewsey JD, Porter SR. Fluticasone case report and review. 2002;47:908-13 (Clin. rev.)
propionate spray and betamethasone sodium phosphate Jih MH (see Kimyai-Asadi and Jih). 2002;47:622-3 (Brief rep.)
mouthrinse: a randomized crossover study for the treatment of Jih MH (see Kimyai-Asadi et al). 2002;47:327-43 (CME article)
symptomatic oral lichen planus. 2002;47:271-9 (Therapy) Jones C (see Zackheim et al). 2002;47:155-7 (Letter)
Heilman ER (see Brown and Heilman). 2002;47:S79-280 (Case Jones D (see Koay et al). 2002;47:608-10 (Case rep.)
rep.) Jones GW, Kacinski BM, Wilson LD, Willemze R, Spittle M, Ho-
Heintz P, Kamino H, Zisblatt M, Orlow SJ (see Zaenglein et al). henberg G, Handl-Zeller L, Trautinger F, Knobler R, EORTC
2002;47:441-4 (Case rep.) Cutaneous Lymphoma Project Group. Total skin electron radi-
Helm TN (see Beutner et al). 2002;47:841-51 ation in the management of mycosis fungoides: consensus of
Hempel M (see Szeimies et al). 2002;47:258-62 (Therapy) the European Organization for Research and Treatment of
Hengge U (see Geraminejad et al). 2002;47:641-55 (CME article) Cancer (EORTC) Cutaneous Lymphoma Project Group. 2002;
Henn W, Zlotogorski A, Lam H, Martinez-Mir A, Zaun H, Chris- +7:304-70
tiano AM. Atrichia with papular lesions resulting from com- Jonkman MF (see Vodegal et al). 2002;47:919-25 (Review)
pound heterozygous mutations in the hairless gene: a lesson JorizzoJ L (see Housman and Jorizzo). 2002;47:S217-20 (Case rep.)
for differential diagnosis of alopecia universalis. 2002;47:519-23 Jorizzo JL (see Sangueza et al). 2002;47:251-7
Henz BM (see Haas et al). 2002;47:5270-2 (Case rep.) Junkins-HopkinJsM (see Shapiro et al). 2002;47:623-8 (Brief rep.),
Hernandez-Martin A, Pinedo F, Pérez-Lescure J. Pustular idio- 2002;47:956-61 (Case rep.)
pathic recurrent palmoplantar hidradenitis: an unusual clinical
feature. 2002;47:S263-5 (Case rep.) K
Herrera-Goepfert R (see Magana and Herrera-Goepfert). 2002;47: Kacinski BM (see Jones et al). 2002;47:304-70
154 (Letter) Kaddu S, Dong H, Mayer G, Kerl H, Cerroni L. Warty dyskera-
Hert M (see Baykal et al). 2002;47:875-80 toma—*follicular dyskeratoma”™: analysis of clinicopathologic
Heymann WR (see Boucher et al). 2002;47:632-3 (Letter) features of a distinctive follicular adnexal neoplasm. 2002;47
Hinrichs R, Fricke O, Tittincti R, Hunzelmann N, Krieg T, Scharf- +23-8 (Dermatopathology)
fetter-Kochanek K. A patient with hyper-IgE syndrome: a mul- Kadunce BV, di Chiacchio N, Almeida ART. Tulle or veil fabric: a
tisystem disorder. 2002;47:5268-9 (Case rep.) versatile option for dressings. 2002;4 129-31 (Pearls)
Hodgson TA (see Hegarty et al). 2002;47:271-9 (Therapy) Kamino H (see Zaenglein et al). 2002;47:441-4 (Case rep.)
Hogewoning CJA (see Bleeker et al). 2002;47:351-7 Kanekura T, Maruyama I, Kanzaki T. Granulocyte and monocyte
Hohenberg G (see Jones et al). 2002;47:364-70 adsorption apheresis for pyoderma gangrenosum
Holloway V (see Lehmann et al). 2002;47:231-40 2002;47:320-1 (Letter)
Holmkvist KA (see Dahl et al). 2002;47:489-92 Kanitakis J (see Skowron et al). 2002;47:5187-8 (Case rep.)
Hordinsky M (see Leyden et al). 2002;47:399-409 (Therapy) Kanwar AJ (see Thami et al). 2002;47:602-3 (Pearls)
Hordinsky M (see Olsen et al). 2002;47:795 (Commentary) Kanzaki T (see Kanekura et al). 2002;47 320-1 (Letter)
Horio T (see Uetsu et al). 2002;47:881-4 (Therapy) Kao J (see Chamlin et al). 2002;47 198-208
Hoss DM (see Chartier et al). 2002;47:809-18 (CME article) Karlberg A-T (see Matura et al). 2002;47:709-14
Housman TS, JorizzoJ L. Anecdotal reports of 3 cases illustrating Karolyi Z (see Erés et al). 2002;47:5260-2 (Case rep.)
a spectrum of resistant common warts treated with cryotherapy Karrer S (see Szeimies et al). 2002;47:258-62 (Therapy)
followed by topical imiquimod and salicylic acid. 2002;47 Kashani-Sabet M (see Zackheim et al). 2002:47:155-7 (Letter
$217-20 (Case rep.) Kato A, Kono T, Ishii M, Wakasa K, Taniguchi S$. Spontaneous
Hsia SL (see Shah et al). 2002;47:241-4 clearance of psoriasis during the course of Kikuchi-Fujimoto
Hughes R, Taylor JS. Surveillance of allergic contact dermatitis: disease. 2002;47:5287-8 (Case rep.)
epoxy resin and microscopic immersion oil. 2002;47:965-6 Kaufman J (see Berman and Kaufman). 2002;47:5209-11 (Cz
(Commentary) rep.)
Hui JI, Linden KG, Barr RJ. Desmoplastic malignant melanoma of Kaur S (see Goraya and Kaur). 2002;47:801 (Letter: notes & com-
the lip: a report of 6 cases and review of the literature. 2002; ments)
+7:803-8 Kaur S (see Thami et al). 2002;47:602-3 (Pearls)
Hunzelmann N (see Hinrichs et al). 2002;47:5268-9 (Case rep.) Kawada A (see Akagi et al). 2002;47:5189-92 (Case rep.)
Hwang LY (see Bogle et al). 2002;47:448-51 (Case rep.) Kawamura C (see Nitta et al). 2002;47:5283-6 (Case rep.)
Kayal JD, McCall CO. Sporotrichoid cutaneous Mycobacterium
I avium complex infection. 2002;47:5249-50 (Case rep.)
Ihn H (see Kubo et al). 2002;47:148-51 (Brief rep.) Kelényi G (see Erés et al). 2002;47:5260-2 (Case rep.)
lijima M (see Nakada et al). 2002:47:5183-6 (Case rep.) Kellman RM (see Duong et al). 2002;47:5193-5 (Case rep.)
984 Author index J} AM ACAD DERMATOL
DECEMBER 2002
Kelly AP (see Taylor et al). 2002;47:770-3 (Special report) laser surgery: a retrospective follow-up study of patients with
Kerdel F (see Romagosa et al). 2002;47:970-2 (Letters: notes & hidradenitis suppurativa. 2002;47:280-5 (Laser surgery)
comments) Larsen FG (see Weismann et al). 2002;47:304-6 (Pearls)
Kerl H (see Kaddu et al). 2002;47:423-8 (Dermatopathology) Lask G (see Lowe et al). 2002;47:834-40
Kernland K (see Szeimies et al). 2002;47:258-62 (Therapy) Lawrence N, Coleman WP III. Liposuction. 2002;47:105-8 (Peri-
Khandpur S, Reddy BS. Itraconazole therapy for white piedra odic synopsis)
affecting scalp hair. 2002;47:415-8 (Therapy) Lawrence RC (see Taylor et al). 2002;47:770-3 (Special report)
Kim JY (see Gelbard et al). 2002;47:224-30 Lazarus GS. Brian Jegasothy, 1943-2001. 2002;47:973-4 (In memo-
Kimball AB, Turner MLC. Mycosis fungoides and serology for riam)
human T-cell lymphotropic virus, type 1. 2002;47:159 (Letter) Lazarus MC (see Shah et al). 2002;47:241-4
Kimball AB (see Chiu et al). 2002;47:633-5 (Letter) LeBoit PE (see Zackheim et al). 2002;47:155-7 (Letter)
Kimball AB (see Taylor et al). 2002;47:770-3 (Special report) Lebwohl M (see Gottlieb et al). 2002;47:692-700
Kimball AB (see Weiss et al). 2002;47:512-7 Lebwohl M (see Persaud and Lebwohl). 2002;47:5236-9 (Case
Kimyai-Asadi A, Jih MH. Indirect hyperbilirubinemia caused by rep.)
cyclosporine. 2002;47:622-3 (Brief rep.) Lebwohl MG (see Persaud et al). 2002;47:553-6
Kimyai-Asadi A, Kotcher LB, Jih MH. The molecular basis of Lee HJ, Chung KY. Erosive adenomatosis of the nipple: conser-
hereditary palmoplantar keratodermas. 2002;47:327-43 (CME vation of the nipple by Mohs micrographic surgery. 2002;47:
article) 578-80 (Derm. surgery)
King LE Jr (see Boyd and King). 2002;47:967-8 (Letters: case notes) Lehmann HP, Robinson KA, Andrews JS, Holloway V, Goodman
Kingsley S. Topical anesthesia: clarification. 2002;47:158-9 (Letter) SN. Acne therapy: a methodologic review. 2002;47:231-40
Kirby B, Owen CM, Blewitt RW, Yates VM. Cutaneous T-cell Lehrer MS (see Shapiro et al). 2002;47:956-61 (Case rep.)
lymphoma developing in a patient on cyclosporin therapy. Leiferman KM (see Drage et al). 2002;47:209-16
2002;47:S105-7 (Case rep.) Lerner AB. A footnote on the origin of fluorosteroids. 2002;47:128
Kirsner RS, Valencia I, Falabella AF, Eaglstein WH. About the (History)
pathophysislogy of venous leg ulcers. 2002;47:158 (Letter re- Levine N (see Salasche et al). 2002;47:571-7 (Therapy)
ply) Lewsey JD (see Hegarty et al). 2002;47:271-9 (Therapy)
Kirsner RS (see Sullivan and Kirsner). 2002;47:439-40 (Pearls) Leyden J, Shalita A, Hordinsky M, Swinyer L, Stanczyk FZ, Weber
Knobler R (see Dittberner et al). 2002;47:452-3 (Letter) M. Efficacy of a low-dose oral contraceptive containing 20 pg
Knobler R (see Jones et al). 2002;47:304-70 of ethinyl estradiol and 100 wg of levonorgestrel for the treat-
Koay J, Jones D, Duvic M. Cold urticaria in a patient with mycosis ment of moderate acne: a randomized, placebo-controlled trial.
fungoides. 2002;47:608-10 (Case rep.) 2002;47:399-409 (Therapy)
Koenig KL (see Gelbard et al). 2002;47:224-30 Liang MG (see Fisler et al). 2002;47:505-11
Kohler S$ (see Chiu et al). 2002;47:633-5 (Letter) Libow LF (see Smith et al). 2002;47:749-54 (Dermatopathology)
Kono T (see Kato et al). 2002;47:S287-8 (Case rep.) Liewehr DJ (see Weiss et al). 2002;47:512-7
Kontoyiannis D (see Bodey et al). 2002;47:659-66 Lifshitz O (see Talpur et al). 2002;47:685-91
Koo H (see Zackheim et al). 2002;47:155-7 (Letter) Lim HW (see Gathers et al). 2002;47:191-7
Koperski JA (see Olsen et al). 2002;47:377-85 Lindberg M (see Swartling et al). 2002;47:667-71
Kopf AW (see Gelbard et al). 2002;47:224-30 Ling M (see Fleischer et al). 2002;47:562-70 (Therapy)
Korman NJ (see Beutner et al). 2002;47:841-51 Lischetzki G (see Neisius et al). 2002;47:28-32
Kotcher LB (see Kimyai-Asadi et al). 2002;47:327-43 (CME article) Lizambri RG (see Gottlieb et al). 2002;47:692-700
Kovacs A (see Erés et al) 2002;47:5260-2 (Case rep.) Llistosella E (see Pujol et al). 2002;47:S168-71 (Case rep.)
Kovacs E (see Fantini et al). 2002;47:319-20 (Letter) Logsetty S (see Salopek et al). 2002;47:785-8 (Case rep.)
Kratochvil FJ III (see Morrison et al). 2002;47:617-20 (Brief rep.) Lorentzen HF (see Weismann et al). 2002;47:304-6 (Pearls)
Krieg T (see Hinrichs et al). 2002;47:5268-9 (Case rep.) Lou W (see Persaud et al). 2002;47:553-6
Kromminga A (see Schmidt et al). 2002;47:133-6 (Case rep.) Loven KH (see Krueger et al). 2002;47:821-33
Krueger GG, Callas KP. Treatment of psoriasis with 6-thioguanine Lowe NJ, Lask G, Yamauchi P, Moore D. Bilateral, double-blind,
and hepatic venoocclusive disease. 2002;47:972 (Letters: notes randomized comparison of 3 doses of botulinum toxin type A
& comments) (Reply) and placebo in patients with crow’s feet. 2002;47:834-40
Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis Lunenfeld E (see Halevy et al). 2002;47:311-3 (Brief rep.)
CN, Alefacept Clinical Study Group. A randomized, double- Lushniak BD (see Carucci et al). 2002;47:766-9 (From the Acad-
blind, placebo-controlled phase III study evaluating efficacy emy)
and tolerability of 2 courses of alefacept in patients with Lust JA (see Brown et al). 2002;47:8506-62
chronic plaque psoriasis. 2002;47:821-33
Kubo M, Ihn H, Asan Y, Yamane K, Yazawa N, Tamaki K. M
Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Jap- MacDonald D (see Millard et al). 2002;47:801-2 (Letter reply: notes
anese patients with polymyositis/dermatomyositis & comments)
2002;47:148-51 (Brief rep.) Magana M, Herrera-Goepfert R. Friction hypermelanosis: other
Kumar B (see Saraswat and Kumar). 2002:47:799-800 (Letter variants, 2002;47:454 (Letter)
notes & comments) Magnusson K (see Matura et al). 2002;47:709-14
Kutzner H (see Pérez et al). 2002;47:21-7 Mahendran R, White SI, Clark AH, Sheehan-Dare RA. Response of
Kutzner H (see Requena et al). 2002;47:371-6 childhood tufted angioma to the pulsed-dye laser. 2002;47:
620-2 (Brief rep.)
i Maher RM (see Fleischer et al). 2002;47:562-70 (Therapy)
Lam H (see Henn et al). 2002;47:519-23 Maino KL (see Boyer et al). 2002;47:938-9 (Pearls)
Lamba S (see Persaud et al). 2002;47:553-6 Malanin K. About the pathophysiology of venous leg ulceration.
LapinsJ , Sartorius K, Emtestam L. Scanner-assisted carbon dioxide 2002;47:157-8 (Letter)
J AM ACAD DERMATOL Author index 985
VOLUME 47, NUMBER 6
Malick F (see Gathers et al). 2002;47:191-7 Morrison L (see Salasche et al). 2002;47:571-7 (Therapy)
Maloney DM, Maloney JE, Dotson D, Popov VL, Sanchez RL. Moxley RT III (see Duong et al). 2002;47:S193-5 (Case rep.)
Cutaneous leishmaniasis: Texas case diagnosed by electron Mrowietz U (see Dichmann et al). 2002;47:635-6 (Letter)
microscopy. 2002;47:614-6 (Case rep.) Mulder M (see Szeimies et al). 2002;47:258-62 (Therapy)
Maloney DM, Schmidt JD, Duvic M. Alitretinoin gel to treat pyo- Myers LM (see Omura et al). 2002;47:950-3 (Case rep.)
genic granuloma. 2002;47:969-70 (Letters: notes & comments)
Maloney JE (see Maloney et al). 2002;47:614-6 (Case rep.) N
Mansouri S (see Eliaszewicz et al). 2002;47:40-6 Naimer SA, Trattner A. Friction hypermelanosis: other variants
Marghoob AA (see Gelbard et al). 2002;47:224-30 2002;47:454-5 (Letter reply)
Marks JG Jr. (see Youker et al). 2002;47:322-3 (Letter) Naji A (see Sharquie et al). 2002;47:159-60 (Letter reply)
Martinez-Mir A (see Henn et al). 2002;47:519-23 Nakada T, Sueki H, lijima M. Disseminated pagetoid reticulosis
Maruyama I (see Kanekura et al). 2002;47:320-1 (Letter) (Ketron-Goodman disease): six-year follow-up. 2002;47:S183-6
Maslo C (see Eliaszewicz et al). 2002;47:40-6 (Case rep.)
Masood N, Russell KJ, OlerudJE , Sabath DE, Sale GE, Doney KC, Natow S (see Bystryn et al). 2002;47:358-63
Flowers MED, Fefer A, Thompson JA. Induction of complete Naver H (see Swartling et al). 2002;47:667-71
remission of advanced stage mycosis fungoides by allogeneic Neisius U, Olsson R, Rukwied R, Lischetzki G, Schmelz M. Pros
hematopoietic stem cell transplantation. 2002;47:140-5 (Brief taglandin E, induces vasodilation and pruritus, but no protein
rep.) extravasation in atopic dermatitis and controls. 2002;47:28-32
Matsuba S (see Suga et al). 2002;47:435-8 (Pearls) Nern K (see Conner et al). 2002;47:347-50
Matura M, Goossens A, Bordalo O, Garcia-Bravo B, Magnusson K, Nguyen FQ (see Weinstock et al). 2002;47:68-72
Wrangsj6 K, Karlberg A-T. Oxidized citrus oil (Rlimonene): a Nichols K, PUVA Follow Up Study (see Stern et al). 2002;47:33-9
frequent skin sensitizer in Europe. 2002;47:709-14 Nie Z (see Shimanovich et al). 2002;47:780-4 (Case rep.)
Mayer G (see Kaddu et al). 2002;47:423-8 (Dermatopathology) Nitta Y, Kawamura C, Hashimoto T. Vesiculobullous systemic
Mays S (see Bodey et al). 2002;47:659-66 lupus erythematosus: a case with circulating IgG and IgA au-
McCall CO, Chen SC. Squamous cell carcinoma of the legs in toantibodies to type VII collagen. 2002;47:S283-6 (Case rep.)
African Americans. 2002;47:524-9 Nomdedeu JF (see Pujol et al). 2002;47:S168-71 (Case rep.)
McCall CO (see Kayal and McCall). 2002;47:5249-50 (Case rep.) Norgauer J (see Dichmann et al). 2002;47:635-6 (Letter)
McCalmont TH (see Zackheim and McCalmont). 2002;47:914-8 Norton SA (see Carucci et al). 2002;47:766-9 (From the Academy)
(Clin. rev.) Norton SA (see Schwartz and Norton). 2002;47:774-5 (Special
McCalmont TH (see Zackheim et al). 2002;47:155-7 (Letter) report)
McClelland M, VanLoock JS, Patterson JW, Greer KE. Radiation- Nousari HC (see DeAmicis et al). 2002;47:5273-4 (Case rep.)
induced morphea occurring after fluoroscopy. 2002;47:962-4
(Case rep.) O
McCrary M (see Brown et al). 2002;47:581-99 (Clin. rev.). Correc- Oclassen G. Charles A. Oclassen, 1907-2001. 2002;47:975 (In
tion 2002;47:972 memoriam)
McEvoy MT (see Bouwhuis et al). 2002;47:63-7 O’Connor MI (see Dahl et al). 2002;47:489-92
McGlone F (see Rukwied et al). 2002;47:245-50 Ogawa H (see Suga et al). 2002;47:435-8 (Pearls)
McGovern TW (see Carucci et al). 2002;47:766-9 (From the Acad- O'Grady T (see Conner et al). 2002;47:347-50
emy) Okamoto H (see Uetsu et al). 2002;47:881-4 (Therapy)
McGuire J (see Chiu et al). 2002;47:633-5 (Letter) Olerud JE (see Masood et al). 2002;47:140-5 (Brief rep.)
Meehan SA (see Zaenglein et al). 2002;47:445-7 (Case rep.) Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM,
Meffert H (see Szeimies et al). 2002;47:258-62 (Therapy) Tschen EH, Trancik RJ. A randomized clinical trial of 5% topical
Mehta RK (see Woodrow et al). 2002;47:600-1 (Pearls) minoxidil versus 2% topical minoxidil and placebo in the treat-
Meigel W (see Pabsch et al). 2002;47:557-61 (Therapy) ment of androgenetic alopecia in men. 2002;47:377-85
Meijer CJLM (see Bleeker et al). 2002;47:351-7 Olsen EA, Hordinsky M, Roberts JL, Whiting DA, Dermatologic
Memar O (see Geraminejad et al). 2002;47:641-55 (CME article) Consortium for Women’s Health. Female pattern hair loss.
Mengesha YM (see Sangueza et al). 2002;47:251-7 2002;47:795 (Commentary)
Mentzel T (see Requena et al). 2002;47:371-6 Olsen EA (see Tosti et al). 2002:47:636-7 (Letter)
Mercurio MG (see Cowen et al). 2002;47:5240-8 (Case rep.) Olsson R (see Neisius et al). 2002;47:28-32
Messenger AG (see Shum et al). 2002;47:733-9 Omura NE, Collison DW, Perry AE, Myers LM. Sebaceous carci-
Mihm MC Jr (see Richardson et al). 2002;47:77-90 (Clin. rev.) noma in children. 2002;47:950-3 (Case rep.)
Millard TP, Harris A, MacDonald D. Acute infantile hemorrhagic Orcel B (see Poszepezynska-Guigné et al). 2002;47:47-52
edema and Henoch-Schénlein purpura: is IgA the missing link?. Orengo I, Rosen T, Guill CK. Treatment of squamous cell carci-
2002;47:801-2 (Letter reply: notes & comments) noma in situ of the penis with 5% imiquimod cream: a case
Miller DM (see Ahmed et al). 2002;47:5196-200 (Case rep.) report. 2002;47:5225-8 (Case rep.)
Mirakhur B (see Boucher et al). 2002;47:632-3 (Letter) Orengo I (see Chen et al). 2002;47:940-1 (Pearls)
Misad C (see Pérez et al). 2002;47:21-7 Orfanos CE (see Treudler et al). 2002;47:611-3 (Case rep.)
Mofid MZ (see DeAmicis et al). 2002;47:S273-4 (Case rep.) Orlow SJ (see Zaenglein et al). 2002;47:441-4 (Case rep.), 2002;
Moore D (see Lowe et al). 2002;47:834-40 +7:445-7 (Case rep.)
Mork C, Wahl A. Improved quality of life among patients with Ostheimer KG (see Albert and Ostheimer). 2002;47:930-7 (Histo-
psoriasis after supervised climate therapy at the Canary Islands. ry)
2002;47:314-6 (Brief rep.) Otley CC (see Berg and Otley). 2002;47:1-17 (CME article)
Morris SE (see Tristani-Firouzi et al). 2002;47:548-52 Otley CC (see Charles et al). 2002;47:419-22 (Derm. surgery)
Morrison L, Kratochvil FJ Ill, Gorman A. An open trial of topical Otten J (see Da Raeve et al). 2002;47:S180-2 (Case rep.)
tacrolimus for erosive oral lichen planus. 2002;47:617-20 (Brief Overstreet KA (see Ross et al). 2002;47:263-70 (Therapy)
rep. ) Owen CM (see Kirby et al). 2002;47:5105-7 (Case rep.)
986 Author index } AM ACAD DERMATOL
DECEMBER 2002
Owens M (see Geisse et al). 2002;47:390-8 Proebstle T (see Szeimies et al). 2002;47:258-62 (Therapy)
Pujol RM, Gallardo F, Llistosella E, Blanco A, Bernard6 L, Bordes
P R, Nomdedeu JF, Servitie O. Invisible mycosis fungoides: a
Pabsch H, Riitten A, von Stemm A, Meigel W, Sander CA, Schaller diagnostic challenge. 2002;47:5168-71 (Case rep.)
J. Treatment of childhood mycosis fungoides with topical Pujol RM (see Brown et al). 2002;47:856-62
PUVA. 2002;4 557-61 (Therapy) Pulkkinen L, Ringpfeil F, UittoJ . Progress in heritable skin dis-
Palacios S (see Piqué et al). 2002;47:5254-6 (Case rep.) eases: molecular bases and clinical implications. 2002;47:91-
Paller AS (see Berlin et al). 2002;47:169-87 (CME article) 104 (Review)
Pandya A (see Geisse et al). 2002;47:390-8 PUVA Follow Up Study (see Stern et al). 2002;47:33-9
Papa CA, Ramsey ML, Tyler WB. Interdigital pilonidal sinus in dog Pye RJ (see Woodrow et al). 2002;47:600-1 (Pearls)
groomer. 2002;47:5281-2 (Case rep.)
Papp KA (see Krueger et al). 2002;47:821-33 R
Parodi A (see Gallo et al). 2002:47:633 (Letter) Raad I (see Bodey et al). 2002;47:659-66
Pas HH (see Vodegal et al). 2002;47:919-25 (Review) Rabeni EJ, Cunningham NM. Effective treatment of Hailey-Hailey
Patterson JW (see McClelland et al). 2002;47:962-4 (Case rep.) disease with topical tacrolimus. 2002;47:797-8 (Letter: case
Pelle MT, Pride HB, Tyler WB. Eccrine angiomatous hamartoma. notes)
2002:47:429-35 (Clin. rev.) Radakovic-Fijan S (see Szeimies et al). 2002;47:258-62 (Therapy)
Pelton S (see Beutner et al). 2002;47:841-51 Radvanyi G. (see Erés et al). 2002;47:5260-2 (Case rep.)
Penso-Assathiany D (see Eliaszewicz et al). 2002;47:40-6 Rady PL (see Geraminejad et al). 2002;47:641-55 (CME article)
Pereira F, Carey W, Shibata H, Burnier MN Jr., Wang B. Multiple Ramsey ML (see Papa et al). 2002;47:5281-2 (Case rep.)
nevoid malignant melanomas in a patient with AIDS: the role of Ranze O (see Dittberner et al). 2002;47:452-3 (Letter)
proliferating cell nuclear antigen in the diagnosis. 2002;47 Rapini RP. Follicular differentiation in basal cell carcinoma and
5172-4 (Case rep.) the trend to designate benign or questionable lesions as ma-
Pérez A, Riitten A, Gold R, Urbina F, Misad C, Izquierdo MJ, lignant. 2002;47:792-4 (Commentary)
Requena C, Aliaga A, Kutzner H, Requena L. Circumscribed Raya-Aguado C (see Alvarez-Cuesta et al), 2002;47:5257-9 (Case
palmar or plantar hypokeratosis: a distinctive epidermal mal- rep.)
formation of the palms or soles. 2002;47:21-7 Rebora A (see Tosti et al). 2002:47:636-7 (Letter)
Pérez-Lescure J (see Hernandez-Martin et al). 2002;47:5263-5 Reddy BS (see Khandpur and Reddy). 2002;47:415-8 (Therapy)
(Case rep.) Reed BR. Safety considerations in the treatment of dermatophyt-
Pérez-Oliva N (see Alvarez-Cuesta et al). 2002;47:5257-9 (Case osis. 2002;47:455-6 (Letter)
rep.) Requena C (see Pérez et al). 2002;47:21-7
Perniciaro C (see Dahl et al). 2002;47:489-92 Requena L, Kutzner H, Mentzel T. Acquired elastotic hemangi-
Perry AE (see Omura et al). 2002:47:950-3 (Case rep.) oma: a clinicopathologic variant of hemangioma. 2002;47:372 1-6
Persaud A, Lebwohl M. Imiquimod cream in the treatment of Requena L (see Pérez et al). 2002;47:21-7
actinic keratoses. 2002;47:5236-9 (Case rep.) Rich P (see Geisse et al). 2002;:47:390-8
Persaud AN, Shamuelova E, Sherer D, Lou W, Singer G, Cervera Richardson SK, Tannous ZS, Mihm MC Jr. Congenital and infantile
C, Lamba $, Lebwohl MG. Clinical effect of imiquimod 5% melanoma: review of the literature and report ofa n uncommon
cream in the treatment of actinic keratosis. 2002;47:553-6 variant, pigment-synthesizing melanoma. 2002;47:77-90 (Clin.
Petersen MJ (see Tristani-Firouzi et al). 2002;47:548-52 rev.)
Pincus SH (see Duong et al). 2002;47:5193-5 (Case rep.) Rico MJ (see Fleischer et al). 2002;47:562-70 (Therapy)
Pinedo F (see Hernandez-Martin et al). 2002;47:S263-5 (Case rep.) Ringpfeil F (see Pulkkinen et al). 2002;47:91-104 (Review)
Pipitone M, RobinsonJ K, Camara C, Chittineni B, Fisher SG. Skin Risica PM (see Weinstock et al). 2002;47:68-72
cancer awareness in suburban employees: a Hispanic perspec- Risse EKJ (see Bleeker et al). 2002;47:351-7
tive. 2002:47:118-23 (Current issues) Ritter S, George R, Serwatka LM, Elston DM. Long-term suppres-
Piqué E, Palacios S, Santana Z. Leukocytoclastic vasculitis pre- sion of chronic Sweet’s syndrome with colchicine. 2002;47:
senting as an erythema gyratum repens-like eruption on a 323-4 (Letter)
patient with systemic lupus erythematosus. 2002;47:S254-6 Roberts JL (see Olsen et al). 2002;47:795 (Commentary)
(Case rep.) Robinson JK (see Pipitone et al). 2002;47:118-23 (Current issues)
Piraccini BM, Ghetti E, Colombo MD (see Tosti et al). 2002:47:73-6 Robinson KA (see Lehmann et al). 2002;47:231-40
(Therapy) Romagosa R, Kerdel F, Shah N. Treatment of psoriasis with 6-thio-
Piraccini BM (see Tosti et al). 2002;47:036-7 (Letter) guanine and hepatic venoocclusive disease. 2002;47:970-2 (Let-
Pittelkow MR (see Bouwhuis et al). 2002:47:63-7 ters: notes & comments)
Pittelkow MR (see Brown et al). 2002;47:856-62 Romano P (see Gottleib et al). 2002;47:692-700
Pizzichetta MA, Argenziano G, Grandi G, de Giacomi C, Trevisan Rook AH (see Shapiro et al). 2002;47:623-8 (Brief rep.), 2002;47:
G, Soyer HP. Morphologic changes of a pigmented Spitz nevus 950-61 (Case rep.)
assessed by dermosc« ypy. 2002;47:137-9 (Case rep.) Rose C (see Shimanovich et al). 2002;47:780-4 (Case rep.)
Plunkett RW (see Beutner et al). 2002;47:841-51 Roseeuw D (see Da Raeve et al). 2002;47:5180-2 (Case rep.)
Pond GR (see Charles et al). 2002;47:419-22 (Derm. surgery) Rosen T (see Orengo et al). 2002;47:5225-8 (Case rep.)
Popov VL (see Maloney et al). 2002;47:614-6 (Case rep.) Ross EV, Cooke LM, Timko AL, Overstreet KA, Graham BS, Bar-
Porter SR (see Hegarty et al). 2002;47:271-9 (Therapy) nette DJ. Treatment of pseudofolliculitis barbae in skin types
Poszepezynska-Guigné E, Viguier M, Chosidow O, Orcel B, Em- IV, V, and VI with a long-pulsed neodymium:yttrium aluminum
merich J, Dubertret L. Paraneoplastic acral vascular syndrome: garnet laser. 2002;47:203-70 (Therapy)
epidemiologic features, clinical manifestations, and disease se- Roth WI (see Zampogna et al). 2002;47:5229-35 (Case rep.)
quelae. 2002;47:47-52 Roujeau J-C (see Eliaszewicz et al). 2002;47:40-6
Price VH (see Tosti et al). 2002:47:636-7 (Letter) Rubenstein DS, Blauvelt A, Chen SC, Darling TN. The future of
Pride HB (see Pelle et al). 2002:4 $29-35 (Clin. rev.) academic dermatology in the United States: report on the res-
} AM ACAD DERMATOL Author index 987
VOLUME 47, NUMBER 6
ident retreat for future physician-scientists, June 15-17, 2001 Schépf E (see Dichmann et al). 2002;47:635-6 (Letter)
2002;47:300-3 (Special report) Schéttler E (see Dittberner et al). 2002:4 :452-3 (Letter)
Rudisell J (see Conner et al). 2002;47:347-50 Schubert B (see Schmidt et al). 2002:47:133-6 (Case rep.)
Ruiz-Rodriguez R, Alvarez JG, jaén P, Acevedo A, Cérdoba S$ Schulman N (see Shapiro et al). 2002;47:623-8 (Brief rep.)
Photodynamic therapy with 5-aminolevulinic acid for recalci- Schwartz J, Norton SA. Useful plants of dermatology. VI. The
trant familial benign pemphigus (Hailey-Hailey disease). 2002; mayapple (Podopbyllum). 2002;47:7 74-5 (Special I report)
47:740-2 (Therapy) Schwartz RA (see Ruocco et al). 2002;47:124-7 (Concepts)
Rukwied R, Zeck $, Schmelz M, McGlone F. Sensitivity of human Schwarzenberger K (see Elston et al). 2002:47:291-9 (Periodic
scalp skin to pruritic stimuli investigated by intradermal micro- synopsis)
dialysis in vivo. 2002;47:245-50 Servitje O (see Pujol et al). 2002;47:S168-71 (Case rep.)
Rukwied R (see Neisius et al). 2002;47:28-32 Serwatka LM (see Ritter et al). 2002;4 323-4 (Letter)
Ruocco E (see Ruocco et al). 2002;47:124-7 (Concepts) Shackelford KE, Belsito DV. The etiology of allergic-appearing
Ruocco V, Schwartz RA, Ruocco E. Lymphedema: an immunolog- foot dermatitis: a 5-year retrospective study. 2002;47:715-21
ically vulnerable site for development of neoplasms. 2002;47 Shah N (see Romagosa et al). 2002;47:970-2 (Letters: notes &
124-7 (Concepts) comments)
Russell KJ (see Masood et al). 2002;47:140-5 (Brief rep.) Shah NS, Lazarus MC, Bugdodel R, Hsia SL, He J, Duncan R,
Riitten A (see Pabsch et al). 2002;47:557-61 (Therapy) Baumann L. The effects of topical vitamin K on bruising after
Riitten A (see Pérez et al). 2002:47:21-7 laser treatment. 2002;47:241-4
Shalita A (see Leyden et al). 2002;47:399-409 (Therapy)
S Shamuelova E (see Persaud et al). 2002;47:553-6
Sabath DE (see Masood et al). 2002;47:140-5 (Brief rep.) Shapiro J (see Tosti et al). 2002;47:636-7 (Letter)
Saffle JR (see Tristani-Firouzi et al). 2002;47:548-52 Shapiro LE, Shear NH. Drug interactions: proteins, pumps, and
Saida T (see Uhara et al). 2002;47:502-4 P-450s. 2002;47:467-84 (CME article)
Saidman BH (see Shapiro et al). 2002;47:623-8 (Brief rep.) Shapiro M, Rook AH, Lehrer MS, Junkins-Hopkins JM, French LE,
Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic kera- Vittorio CC. Novel multimodality biologic response modifier
toses of the face and scalp with 5% topical imiquimod cream therapy, including bexarotene and long-wave ultraviolet A for
an open-label trial. 2002;47:571-7 (Therapy) a patient with refractory stage [Va cutaneous T-cell lymphoma
Salcedo SL (see Jih et al). 2002;4 7:908-13 (Clin. rev.) 2002;47:956-61 (Case rep.)
Sale GE (see Masood et al). 2002;47:140-5 (Brief rep.) Shapiro M, Yun M, Junkins-Hopkins JM, Vittorio CC, Schulman N,
Salomon D (see Szeimies et al). 2002;47:258-62 (Therapy) Saidman BH, Fried RG, Rook AH, Alavi A. Assessment of tumor
Salopek TG, Logsetty S, Tredget EE. Anti-CD20 chimeric mono- burden and treatment response by 18F-fluorodeoxyglucose
clonal antibody (rituximab) for the treatment of recalcitrant, injection and positron emission tomography in patients with
life-threatening pemphigus vulgaris with implications in the cutaneous T- and B-cell lymphomas. 2002;47:623-8 (Brief rep.)
pathogenesis of the disorder. 2002;47:785-8 (Case rep.) Sharquie KE, Al-Waiz M, Naji A. Mycosis fungoides and serology
Sanchez RL (see Maloney et al). 2002;47:614-6 (Case rep.) for human T-cell lymphotropic virus, type 1. 2002;47:159-60
Sander CA (see Pabsch et al). 2002;47:557-61 (Therapy) (Letter reply)
Sangueza OP, Caudell MD, Mengesha YM, Davis LS, Barnes CJ, Shear NH (see Shapiro and Shear). 2002;47:467-84 (CME article)
Griffin JE, Fleischer AB, JorizzJoL . Palisaded neutrophilic gran- Sheehan-Dare RA (see Mahendran et al). 2002;47:620-2 (Brief
ulomatous dermatitis in rheumatoid arthritis. 2002;47:251-7 rep.)
Santana Z (see Piqué et al). 2002;47:5254-6 (Case rep.) Sherer D (see Persaud et al). 2002:47:553-6
Saraswat A, Kumar B. Dermatoses of pregnancy: rose of circulat- Sheu MY (see Chamlin et al). 2002;47:198-208
ing fetal cells. 2002;47:799-800 (Letter: notes & comments) Shibata H (see Pereira et al). 2002;47:S172-4 (Case rep.)
Sartorius K (see Lapins et al). 2002;47:280-5 (Laser surgery) Shimanovich I, Skrobeck C, Rose C, Nie Z. Hashimoto T, Brécker
Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of E-B, Zillikens D. Pemphigoid gestationis with predominant
dandruff with 5% tea tree oil shampoo. 2002;47:852-5 involvement of oral mucous membranes and IgA autoantibod-
Satoi Y (see Fleischer et al). 2002;47:562-70 (Therapy) ies targeting the C-terminus of BP 180. 2002;47:780-4 (Case rep.)
Sauder DN, DeKoven J, Champagne P, Croteau D, Dupont E Shuey SR (see Gottleib et al). 2002;47:692-700
Neovastat (4E-941), an inhibitor of angiogenesis: randomized Shum KW, Cullen DR, Messenger AG. Hair loss in women with
phase I/II clinical trial results in patients with plaque psoriasis hyperandrogenism: four cases responding to finasteride. 2002;
2002:47:535-41 +7:733-9
Saurajen A (see Satchell et al). 2002:47:852-5 Sidoroff A (see Szeimies et al). 2002;47:258-62 (Therapy)
Saurat J-H (see Friedli et al). 2002;47:5200-7 (Case rep.) Sinclair R (see Tosti et al). 2002:47:630-7 (Letter)
Scarabello A (see Fantini et al). 2002;47:319-20 (Letter) Sinclair RD (see Thai and Sinclair). 2002;47:605-7 (Case rep.)
Schaller J (see Pabsch et al). 2002;47:557-61 (Therapy) Singer G (see Persaud et al). 2002;47:553-(
Scharffetter-Kochanek K (see Hinrichs et al). 2002;:47:S268-9 (Case Sitaru C (see Schmidt et al). 2002;47:133-6 (Case rep.)
rep.) Skinner RB Jr. Treatment of molluscum contagiosum with imi-
Scherschun L (see Gathers et al). 2002;47:191-7 quimod 5% cream. 2002;47:5221-4 (Case rep.)
Schmelz M (see Neisius et al). 2002;47:28-32 Skowron F, Combemale P, Faisant M, Baran R, KanitakisJ ,D upin
Schmelz M (see Rukwied et al). 2002:47:245-50 M. Functional melanonychia due to involvement of the nail
Schmidt E, Sitaru C, Schubert B, Wesselmann U, Kromminga A, matrix in systemic lupus erythematosus. 2002;47:5187-8 (Case
Brécker E-B, Zillikens D. Subacute prurigo variant of bullous rep.)
pemphigoid: autoantibodies show the same specificity com- Skrobeck C (see Shimanovich et al). 2002;47:780-4 (Case rep.)
pared with classic bullous pemphigoid. 2002;47:133-6 (Case Smith EB. Safety considerations in the treatment of dermatophyt-
rep.) osis. 2002;47:456-7 (Letter reply)
Schmidt JD (see Maloney et al). 2002;47:969-70 (Letters: notes & Smith KJ, Germain M, YeagerJ , Skelton H. Topical 5% imiquimod
comments) for the therapy of actinic cheilitis. 2002;47:497-501
988 Author index J AM ACAD DERMATOL
DECEMBER 2002
Smith SB, Libow LF, Elston DM, Bernert RA, Warschaw KE. Tebbe B, Steinhoff M, Orfanos CE (see Treudler et al). 2002;47:
Gloves and socks syndrome: early and late histopathologic 611-3 (Case rep.)
features. 2002;47:749-54 (Dermatopathology } Thai K-E, Sinclair RD. Chronic telogen effluvium in a man. 2002;
Soriano T (see Grimes et al). 2002;47:789-91 (Brief rep.) +7:605-7 (Case rep.)
Soyer HP (see Pizzichetta et al). 2002;47:137-9 (Case rep.) Thami GP, Kaur S, Kanwar AJ. Surgical pearl: enucleation of milia
Spittle M (see Jones et al). 2002;47:304-70 with a disposable hypodermic needle. 2002;47:602-3 (Pearls)
Spray A, Glaser DA. Herpes zoster of the penis: an unusual Thiboutot D. Acne: 1991-2001. 2002;47:109-17 (Periodic synopsis)
location for a common eruption. 2002;47:5177-9 (Case rep.) Thoma-Uszynski S$ (see Baykal et al). 2002;47:875-80
Spruance SL. N-docosanol (Abreva) for herpes labialis: problems Thompson JA (see Masood et al). 2002;47:140-5 (Brief rep.)
and questions. 2002;47:457-8 (Letter) Timko AL (see Ross et al). 2002;47:263-70 (Therapy)
Stanczyk FZ (see Leyden et al). 2002;47:399-409 (Therapy) Tope WD (see Ahmed et al). 2002;47:5196-200 (Case rep.)
Starink TM (see Bleeker et al). 2002;47:351-7 Tortel J (see Grange et al). 2002;47:530-4
Steinhoff M (see Treudler et al). 2002;47:611-3 (Case rep.) Tortel M-C (see Grange et al). 2002;47:530-4
Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study. The Tosti A, Piraccini BM, Bergfeld WF, Camacho F, Dawber RPR,
persistent risk of genital tumors among men treated with pso- Happle R, Olsen EA, Price VH, Rebora A, ShapiroJ , Sinclair R,
ralen plus ultraviolet A (PUVA) for psoriasis. 2002;47:33-9 VanNeste D, Whiting DA. Occupational alopecia or alopecia
Stough DB (see Krueger et al). 2002;47:821-33 areata?. 2002;47:030-7 (Letter)
Sueki H (see Nakada et al). 2002;47:5183-6 (Case rep.) Tosti A, Piraccini BM, Ghetti E, Colombo MD. Topical steroids
Suga Y, Ikejima A, Matsuba $, Ogawa H. Medical pearl: DHA versus systemic antifungals in the treatment of chronic paro-
application for camouflaging segmental vitiligo and piebald nychia: an open, randomized double-blind and double dummy
lesions. 2002;47:435-8 (Pearls) study. 2002;47:73-6 (Therapy)
Sugarman JH, Fleischer AB Jr., Feldman SR. Off-label prescribing Totoritis MC (see Gottleib et al). 2002;47:692-700
in the treatment of dermatologic disease. 2002;47:217-23 Toy GG (see Alli and Toy). 2002;47:967 (Letters: case notes)
Sullivan TP, Kirsner RS. Surgical pearl: punch technique to im- Trancik RJ (see Olsen et al). 2002;47:377-85
prove granulation over exposed tendons in chronic wounds. Trattner A (see Naimer and Trattner). 2002;47:454-5 (Letter reply)
2002;47:439-40 (Pearls) Trautinger F (see Jones et al). 2002;47:364-70
Sundel RP (see Fisler et al). 2002;47:505-11 Tredget EE (see Salopek et al). 2002;47:785-8 (Case rep.)
Swartling C, Naver H, Lindberg M, Anveden I. Treatment of Trehan M, Taylor CR. Medium-dose 308-nm excimer laser for the
dyshidrotic hand dermatitis with intradermal botulinum toxin. treatment of psoriasis. 2002;47:701-8
2002;47:067-71 Treudler R, Tebbe B, Steinhoff M, Orfanos CE. Familial aquagenic
Swinehart JM (see Olsen et al). 2002;47:377-85 urticaria associated with familial lactose intolerance. 2002;47:
Swinyer L (see Leyden et al). 2002;47:399-409 (Therapy) 611-3 (Case rep.)
Szeimies RM, Karrer S, Radakovic-Fijan $, Tanew A, Calzavara- Trevisan G (see Pizzichetta et al). 2002;47:137-9 (Case rep.)
Pinton PG, Zane C, Sidoroff A, Hempel M, Ulrich J, Proebstle T, Tripp JM (see Gelbard et al). 2002;47:224-30
Meffert H, Mulder M, Salomon D, Dittmar HC, Bauer JW, Kern- Tristani-Firouzi P, Petersen MJ, Saffle JR, Morris SE, Zone JJ.
land K, Braathen L. Photodynamic therapy using topica! methyl Treatment of toxic epidermal necrolysis with intravenous im-
5-aminolevulinate compared with cryotherapy for actinic ker- munoglobulin in children. 2002;47:548-52
atosis: a prospective, randomized study. 2002;47:258-62 (Ther- Trontell A (see Brinker et al). 2002;47:798-9 (Letter: notes &
apy) comments)
Tschen EH (see Olsen et al). 2002;47:377-85
r
Tschen JA (see Bogle et al). 2002;47:448-51 (Case rep.)
Tachihara R (see Yun et al). 2002;47:542-7 Turner ML (see Weiss et al). 2002;47:512-7
Tacrolimus Ointment Study Group (see Fleischer et al). 2002;47: Turner MLC. (see Kimball and Turner). 2002;47:159 (Letter)
502-70 (Therapy) Tiitiincii R (see Hinrichs et al). 2002;47:5268-9 (Case rep.)
Tajima S (see Akagi et al). 2002;47:5189-92 (Case rep.) Tyler WB (see Papa et al). 2002;47:5281-2 (Case rep.)
Takacs A (see Erés et al). 2002;47:5260-2 (Case rep.) Tyler WB (see Pelle et al). 2002;47:429-35 (Clin. rev.)
Takizawa Y (see Uhara et al). 2002;47:502-4 Tyring SK (see Brown et al). 2002;47:581-99 (Clin. rev.). Correc-
Talpur R, Lifshitz O, Breuer-McHam J, Duvic M. Increased serum tion 2002;47:972
immunoglobulin levels are common in mycosis fungoides and Tyring SK (see Carrasco et al). 2002;47:5212-6 (Case rep.)
Sézary syndrome. 2002;47:685-91 Tyring SK (see Geraminejad et al). 2002;47:641-55 (CME article)
Talpur R, Ward S, Apisarnthanarax N, Breuer-McHamJ , Duvic M.
Optimizing bexarotene therapy for cutaneous T-cell lym- l
phoma. 2002;47:672-84 Uetsu N, Okamoto H, Fujii K, Doi R, Horio T. Treatment of
Tamaki K (see Kubo et al). 2002;47:148-51 (Brief rep.) chronic actinic dermatitis with tacrolimus ointment. 2002;47:
Tanew A (see Szeimies et al). 2002;47:258-62 (Therapy) 881-4 (Therapy)
Taniguchi S (see Kato et al). 2002;47:S287-8 (Case rep.) Uhara H, Saida T, Watanabe T, Takizawa Y. Lymphangitis of the
Tannous Z (see Gonzalez and Tannous). 2002;47:869-74 foot demonstrating lymphatic drainage pathways from the sole.
Tannous ZS (see Richardson et al). 2002;47:77-90 (Clin. rev.) 2002;47:502-4
Taylor CR (see Trehan and Taylor). 2002;47:701-8 UittoJ . Herbert A. Luscombe, 1916-2002. 2092;47:976(I n memo-
Taylor JS (see Carucci et al). 2002;47:766-9 (From the academy) riam)
Taylor JS (see Hughes and Taylor). 2002;47:965-6 (Commentary) Uitto J (see Pulkkinen et al). 2002;47:91-104 (Review)
Taylor SC, Kelly AP, Dupree NE, Kimball AB, Lawrence RC. Ulrich J (see Szeimies et al). 2002;47:258-62 (Therapy)
Health disparities in arthritis and musculoskeletal and skin Urbina F (see Pérez et al). 2002;47:21-7
diseasesCthe dermatology session: National Institute of Arthritis
Vv
and Musculoskeletal and Skin Diseases, Bethesda, Maryland,
December 15-16, 2000. 2002;47:770-3 (Special report) Valencia I (see Kirsner et al). 2002;47:158 (Letter reply)